![](/img/cover-not-exists.png)
Open-label Phase II study of everolimus plus endocrine therapy in postmenopausal women with ER-positive and HER2-negative metastatic breast cancer (Chloe trial)
Shimoi, Tatsunori, Shimomura, Akihiko, Shien, Tadahiko, Uemura, Yukari, Kato, Hiroaki, Kitada, Masahiro, Toyama, Tatsuya, Aihara, Tomohiko, Mukai, HirofumiVolume:
Volume 10
Language:
english
Journal:
Open Access Journal of Clinical Trials
DOI:
10.2147/OAJCT.S155706
Date:
February, 2018
File:
PDF, 261 KB
english, 2018